The 5th International Porto Congress of Multiple Sclerosis took place between the 14th and 16th of February 2019 in Porto, Portugal. Its intensive programme covered a wide-range of themes—including many of the hot topics, challenges, pitfalls and yet unmet needs in the field of multiple sclerosis (MS)—led by a number of well-acknowledged world experts. This meeting review summarizes the talks that took place during the congress, which focussed on issues in MS as diverse as the development and challenges of progressive MS, epidemiology, differential diagnosis, medical management, molecular research and imaging tools
(MSIF), established in 1967, links the activities of more than 85 national MS societies worldwide. O...
Individuals with multiple sclerosis (MS) spasticity present a wide range of symptoms and disability ...
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -...
Abstract The 5th International Porto Congress of Multiple Sclerosis took place between the 14th and ...
This article is based on the ECTRIMS lecture given at the 25(th) ECTRIMS meeting which was held in D...
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous syste...
Exercise as a subset of physical activity is a cornerstone in the management of multiple sclerosis (...
Exercise as a subset of physical activity is a cornerstone in the management of multiple sclerosis ...
Multiple sclerosis (MS) is a chronic neurological disease which often leads to disability. The compl...
ABSTRACT The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective...
International audienceOn 12 September 2019, the global Patient Reported Outcome for Multiple Scleros...
Despite significant progress in the development of therapies for relapsing MS, progressive MS remain...
Background: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system ...
Background: Eliciting the research priorities of people affected by a condition, carers and health c...
AbstractMultiple sclerosis (MS) is the most famous autoimmune disease attacking the central nervous ...
(MSIF), established in 1967, links the activities of more than 85 national MS societies worldwide. O...
Individuals with multiple sclerosis (MS) spasticity present a wide range of symptoms and disability ...
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -...
Abstract The 5th International Porto Congress of Multiple Sclerosis took place between the 14th and ...
This article is based on the ECTRIMS lecture given at the 25(th) ECTRIMS meeting which was held in D...
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous syste...
Exercise as a subset of physical activity is a cornerstone in the management of multiple sclerosis (...
Exercise as a subset of physical activity is a cornerstone in the management of multiple sclerosis ...
Multiple sclerosis (MS) is a chronic neurological disease which often leads to disability. The compl...
ABSTRACT The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective...
International audienceOn 12 September 2019, the global Patient Reported Outcome for Multiple Scleros...
Despite significant progress in the development of therapies for relapsing MS, progressive MS remain...
Background: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system ...
Background: Eliciting the research priorities of people affected by a condition, carers and health c...
AbstractMultiple sclerosis (MS) is the most famous autoimmune disease attacking the central nervous ...
(MSIF), established in 1967, links the activities of more than 85 national MS societies worldwide. O...
Individuals with multiple sclerosis (MS) spasticity present a wide range of symptoms and disability ...
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -...